日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Molecular-Guided Precision Oncology in Cancer of Unknown Primary: A State-of-the-Art Perspective

分子引导的精准肿瘤学在原发灶不明癌症中的应用:最新进展

Subbiah, Vivek; Rassy, Elie; Greco, Frank A

Advancing precision antibody-drug conjugate therapy: unique proteogenomic profiles of tumor subsets in non-small cell lung cancer

推进精准抗体药物偶联疗法:非小细胞肺癌肿瘤亚群的独特蛋白质基因组学特征

Lin, Edwin; Lo, Ying-Chun; Subbiah, Vivek; Thawani, Rajat; Desai, Aakash

Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types

在超过 8000 名涵盖 24 种癌症类型的患者中,肿瘤突变负荷与免疫检查点抑制剂治疗后的生存率之间的关系

Gandara, David R; Agarwal, Neeraj; Gupta, Shilpa; Klempner, Samuel J; Andrews, Miles C; Mahipal, Amit; Subbiah, Vivek; Eskander, Ramez N; Carbone, David P; Riess, Jonathan W; Sammons, Sarah; Snider, Jeremy; Bouzit, Lilia; Cho-Phan, Cheryl; Price, Megan; Li, Gerald; Quintanilha, Julia C F; Huang, Richard Sheng Poe; Ross, Jeffrey S; Fabrizio, David; Oxnard, Geoffrey R; Graf, Ryon P

Selpercatinib mitigates cancer cachexia independent of anti-tumor activity in the HT1080 tumor model

在HT1080肿瘤模型中,Selpercatinib可减轻癌症恶病质,且该作用独立于其抗肿瘤活性。

Khatri, Ujjwol; Gouda, Mohamed A; Pandey, Shriya; Chauhan, Neeraj K; Shen, Tao; Hu, Xueqing; Li, Min; Huang, Suming; Subbiah, Vivek; Wu, Jie

P05.19.A CLINICAL OUTCOME OF BIOMARKER-GUIDED THERAPIES IN ADULT NEURO-ONCOLOGY PATIENTS: AN UPDATE FROM THE TÜBINGEN MOLECULAR TUMOR BOARD COHORT

P05.19.A 生物标志物指导治疗在成人神经肿瘤患者中的临床结果:来自蒂宾根分子肿瘤委员会队列的最新进展

Horgan, Denis; Paulson, Joseph N; Loaiza-Bonilla, Arturo; Svedman, Christer; Malapelle, Umberto; Penault-Llorca, Frédérique; Rahsheed, Hadi Mohamad Abu; Hofman, Paul; Kachnowski, Stan; Schneider, Daniel; Subbiah, Vivek; Rieger, D; Becker, H; Walter, B; Doerner, L; Kurz, S; Gani, C; Neumann, M; Rieß, O; Schroeder, C; Ossowski, S; Fend, F; Singer, S; Nahnsen, S; Ernemann, U; Sundberg-Malek, H; Schittenhelm, J; Bitzer, M; Malek, N; Tatagiba, M; Renovanz, M; Tabatabai, G

Targeting Oncogenic RET Kinase by Simultaneously Inhibiting Kinase Activity and Degrading the Protein

通过同时抑制激酶活性和降解蛋白质来靶向致癌RET激酶

Wang, Yafeng; Hu, Xueqing; Pandey, Shriya; Khatri, Ujjwol; Shen, Tao; Subbiah, Vivek; Mooers, Blaine H M; Chao, Ting; Wang, Shaohui; Yu, Huaxuan; Sun, Xingmin; Wu, Jie; Cai, Jianfeng

Larotrectinib Compared With Real-World Non-Tropomyosin Receptor Kinase Inhibitor Therapies in Patients With Tropomyosin Receptor Kinase Fusion Cancer

拉罗替尼与真实世界中非原肌球蛋白受体激酶抑制剂疗法在原肌球蛋白受体激酶融合癌患者中的比较

Brose, Marcia S; Westphalen, C Benedikt; Pan, Xiaoyun; Bernard-Gauthier, Vadim; Kurtinecz, Milena; Guo, Helen; Aris, Virginie; Brett, Neil R; Majdi, Abdelali; Subbiah, Vivek; Pennell, Nathan A; Kehl, Kenneth L; Drilon, Alexander

Guide to Understanding and Supporting International Medical Graduates in Hematology/Oncology by the ASCO International Medical Graduates Community of Practice

美国临床肿瘤学会国际医学毕业生实践社区《理解和支持血液学/肿瘤学领域国际医学毕业生的指南》

Dizman, Nazli; Bakouny, Ziad; Haykal, Tarek; Riano, Ivy; Desai, Aakash; Butt, Ayesha; Basu, Arnab; Zhao, Dan; Saad, Eddy; Saliby, Renee Maria; Gosain, Rohit; Gosain, Rahul; Ardeshir, Fatemeh; Deng, Lei; Matt-Amaral, Laurie; Arnaoutakis, Konstantinos; Bekaii-Saab, Tanios; Manochakian, Rami; Marshall, Ariela; Forde, Patrick; Murphy, Martina; Subbiah, Vivek; Chavez-MacGregor, Mariana; Owonikoko, Taofeek K; Lopes, Gilberto; Aggarwal, Charu; Lee, Alfred I; Choueiri, Toni K

Phase Ia/b Multicenter Study of BPM31510IV Targeting Mitochondrial Metabolism/Warburg Effect as Monotherapy and Combination Chemotherapy in Solid Tumor Patients

BPM31510IV靶向线粒体代谢/瓦博格效应的Ia/b期多中心研究:单药治疗及联合化疗治疗实体瘤患者

Subbiah, Vivek; Yu, Peter P; Sarangarajan, Rangaprasad; Kiebish, Michael A; Rodrigues, Leonardo O; Miller, Gregory M; Akmaev, Viatcheslav R; Luan, Shen; McCook, John P; Tanna, Nikunj; Reilly, Tracey; Chen, Emily; Bussberg, Valerie; Ravipaty, Shobha; Vishnudas, Vivek K; Gesta, Stephane; Lucius, David; Bruce, Can; Hazarika, Suwagmani; Lyng, Arianne; Klotz, Allison; Tolstikov, Vladimir; Stevens, Janice; Chua, Victoria S; Granger, Elder; Tekumalla, Poornima K; Benaim, Ely; Modur, Vijay; Rudoltz, Marc S; Song, Paul Y; Tagawa, Scott T; Hendifer, Andrew; Chawla, Sant P; Shah, Manish A; Hong, David S; Zinner, Ralph; Narain, Niven R; Kundranda, Madappa N

Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial

来非托利莫德联合伊匹木单抗治疗晚期实体瘤患者:一项 I 期试验

Nardo, Mirella; Gouda, Mohamed A; Reilley, Matthew J; Biter, Amadeo B; Lim, Joann; Bean, Stacie A; Nguyen, Ly M; Bhosale, Priya R; Ager, Casey R; Couillault, Coline A; Piha-Paul, Sarina A; Fu, Siqing; Tsimberidou, Apostolia M; Yap, Timothy A; Naing, Aung; Rodon, Jordi; Subbiah, Vivek; Karp, Daniel D; Curran, Michael A; Hong, David S